ArticleBMC gastroenterology2025
Vedolizumab-steroid combination therapy improves long-term prognosis in patients with ulcerative colitis.
Yosuke Yamada et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it